Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Venus Remedies gets Saudi FDA approval for speciality oncology therapy
Venus Remedies Limited has secured its first global marketing authorization for its specialty oncology therapy, Plerixafor, from the Saudi Food and Drug Authority (SFDA). This hematopoietic stem cell mobilizer is crucial for patients undergoing stem cell transplantation for multiple myeloma and non-Hodgkin lymphoma.
Venus Remedies expands Latin America presence with Argentina nod for antibiotic
Venus Remedies has received approval in Argentina for its antibiotic Ceftriaxone. This marks a significant step in the company's Latin America expansion. Argentina is a key market for critical care therapies. Ceftriaxone is vital for treating serious bacterial infections. This authorization strengthens Venus Remedies' global presence and commitment to accessible anti-infective treatments.
Momentum Stocks: Solex Energy, Sagardeep Alloy, Grand Continent rally sheer momentum
A few stocks saw sharp intraday moves and hit upper circuits. Venus Remedies, Modison, Gujarat Raffia Industries, GE Power India were locked in the upper band, reflecting strong demand and limited supply—often a sign of bullish near-term sentiment.
Momentum Stocks: Coffee Day Enterprises, E2E Networks, Hitech Corporation hit upper circuit
Coffee Day Enterprises, E2E Networks, Hitech Corporation, Venus Remedies were locked in the upper band, reflecting strong demand and limited supply—often a sign of bullish near-term sentiment.